Gland Cytopathology" (MSRSGC). 8, 9 This system defines a six-tiered classification scheme and the categories include nondiagnostic (ND), non-neoplastic (NN), atypia of undetermined significance (AUS), neoplasm (benign neoplasm, BN, and salivary gland neoplasm of uncertain malignant potential, SUMP), suspicious for malignancy (SM) and malignant (M) ( Table 1) . Each diagnostic category is associated with a known malignancy risk (Table 1) . Herein, we applied the MSRSGC to salivary gland specimens diagnosed at our institution and compared it with the previously used classification system. In addition, risks of malignancy (ROM) for each category were assessed. Our previously used classification system corresponded to an in-house classification and categories were defined as follows: nondiagnostic, benign, atypical, neoplastic, suspicious for malignancy and malignant.
| MATERIAL AND METHODS

| Case collection and evaluation
The study was planned as exempt by the ethics committee and conforms to the standards of the Helsinki Accord. Since the study is retrospectively designed, no protected health information was used and patient consent was not obtained.
All salivary gland cytology specimens from January 2011 to December 2017 of the Acıbadem University pathology archive were retrieved (388 cases). Additional information were collected from the clinical files and are showed in Table 2 . Histologic samples were considered the gold standard and were available in 104 cases (26.8%).
All cytological cases were retrospectively reviewed by two experienced cytopathologists (S.C. and O.A.) and categorized by the recent MSRSGC. The conventional classification system was recorded considering the previous case reports.
| Statistical analysis
Statistical analysis was executed using NCSS (Number Cruncher Statistical System) 2007 (Kaysville, Utah). Standard descriptive analysis was performed. Risk of malignancy was defined for each category as number of confirmed malignant cases/total number of cases in diagnostic category. Sensitivity, specificity, positive and negative predictive values (PPV, NPV) and accuracy ratios were calculated using histologic diagnosis as the gold standard. The cytologic diagnostic categories were successively set as diagnostic threshold, that is, "cutpoint." Categories with risks of malignancy equal to or greater than the "cut-point" category were combined as a group, which was defined as positive test whereas categories with risks of malignancy lower than the "cut-point" category were combined as a group, which was defined as negative test and for each of these combinations, the sensitivity, specificity, accuracy rate and Youden index were calculated.
Based on the sensitivity and specificity associated with various combinations aforementioned, a receiver operating characteristic (ROC) curve was plotted and the area under the receiver operating characteristic curve (AUROC) was subsequently calculated. The value of AUROC was interpreted as 0.5 (no discriminatory power) to 1.0 (perfect discrimination). The AUROC for the MSRSGC and for the old classification were compared by the DeLong method. 10 
| RESULTS
The patients' demographic data and lesions characteristics are summarized in Table 2 . The aspirates were assigned six-categories using the Milan system also comprises six categories, described in Table 1 . A total of 388 salivary gland specimens were classified according to the old system as: ND 7.2% (n = 28); B 63.4% (n = 246); A 9.3% (n = 36); (n = 14) (Figure 1 ). When applying the binary system to calculate diagnostic yield (considering only benign and malignant cases), both classifications showed the same sensitivity (62.5%) and specificity (100%).
PPV, NPV and diagnostic accuracy were also very similar (Table 3) .
When grouping AUS, NUMP, SM and M categories altogether as a positive test result, using the Milan system, the sensitivity, specificity and accuracy rate associated with this combination were 70.59%, The ROM were calculated for both the old system and the Milan system and are detailed in Tables 4 and 5 .
| DISCUSSION
The management of salivary gland lesions is usually based on clinical and imaging findings in association with cytological evaluation. FNA is commonly reported to have fewer complications when compared to core biopsy and with less potential for tumor seeding. 5 Nonetheless, some recent studies question this assumption and defend the use of core biopsy as safe and with potentially superior diagnostic yield.
11,12
Notwithstanding, FNA is certainly a less costly option which can be performed on a one-stop clinic setting and most studies find it an excellent pre-surgical triage tool, distinguishing accurately neoplastic from non-neoplastic lesions. 13 In our series, we included mainly parotid and submandibular lesions. There were not sublingual or minor salivary gland lesions represented in our sample. The majority of cases corresponded to benign / non-neoplastic lesions, as is the case for most studies. [14] [15] [16] The B category in the old classification encompassed the most number of cases (n = 246), since it included both non-neoplastic lesions and benign neoplasms, corresponding fairly to the NN and the BN categories of the Milan classification (245 cases in total). The one case that was considered benign in the old classification and was not We evaluated ROM using both the old and the new classification systems (Tables 4 and 5 ). When comparing our results using the Milan system and the reported ROM values for this classification we find that we have a good concordance overall. NN category showed a superior ROM value (33.3%) than expected (10%), 9 which can be explained since only six cases on this category had corresponding histological specimen, and four turned out to be malignant (1 adenoid cystic carcinoma and 3 metastases to salivary gland). All these cases had a cystic component, which might have contributed to sampling error. A more representative sample will probably avert this issue. Our AUS ROM value (9.1%) was on the lower limit of the reported ROM for this category (10%-35%). 9 The BN category had a ROM of 1.63%, in accordance to the expected value of less than 5%. ND, SUMP, SM When evaluating sensitivity, specificity, PPV, NPV and accuracy rates (for detecting malignancy) we found that both classifications presented similar values, almost perfectly overlapping (refer to Table 3 ). The reported values in most series for FNA sensitivity and specificity vary between 86%-100% and 90%-100%, respectively. 7, 9, 18 In our study, specificity was 100% (using both classifications), but the sensitivity was lower than expected (62.5%). Albeit some other studies also reported lower sensitivity values (such as 57%) 19 it can be difficult to compare these values between studies due to methodological differences (namely different approaches to the statistical analysis). Probably the considerable number of nonmalignant lesions in our sample might also have contributed to this outcome. In accordance to the relatively low sensitivity and high specificity values, NPV was lower (95.5%) than PPV (100%). Of note, one limitation of our study is the relatively small number of cases (n = 104) with corresponding histology. Another important remark is that our study is based only on specimens with corresponding histological specimens. This can lead to verification bias and cause overestimation of sensitivity and underestimation of specificity. This can affect the absolute estimates but the comparison between systems will still be valid because the bias would affect both systems in the same way.
When grouping AUS, NUMP, SM and M categories altogether (using the Milan classification) as a positive test result, the sensitivity, specificity and accuracy rate were 70.59%, 88.89% and 86%, respectively. This combination yielded the maximum value of the Youden index, meaning the best combination of the sensitivity and specificity.
Similarly, for the old classification, the best diagnostic combination was achieved when grouping A, N, SM and M categories as a positive test result, with identical values comparing to the new system.
When comparing the old and new classification systems, the AUROC were 0.808 and 0.767, respectively, and there was no statistically significant difference between them (P = 0.148), meaning that both systems performed similarly in our sample, with a good discriminatory value.
| CONCLUSION
Salivary gland FNA has a high diagnostic accuracy and is valuable in the pre-surgical setting, independently of the classification system used. Nonetheless, in difficult or ambiguous cases the use of the Milan system could be beneficial since it allows for a better stratification of diagnostic categories and corresponding malignancy risk values, namely with the distinction of benign neoplasms from other benign entities and the introduction of a SUMP category. 
